High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.6M
$1,575,008
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
NRIX
S
Nurix Therapeutics, Inc.
Ring Christine
• Officer • Chief Legal Officer
10b5-1 SellΔOwn -19.1%
2026-03-02
$125,793
|
||||||
| NRIX |
Nurix Therapeutics, Inc.
|
Officer • Chief Legal Officer
10b5-1 SellΔOwn -19.1%
|
2026-03-02 | $125,793 | S | Form 4 |
|
NRIX
S
Nurix Therapeutics, Inc.
Ring Christine
• Officer • Chief Legal Officer
10b5-1 SellΔOwn -25.0%
2026-02-09
$237,618
|
||||||
| NRIX |
Nurix Therapeutics, Inc.
|
Officer • Chief Legal Officer
10b5-1 SellΔOwn -25.0%
|
2026-02-09 | $237,618 | S | Form 4 |
|
NRIX
S
Nurix Therapeutics, Inc.
Hansen Gwenn
• Officer • Chief Scientific Officer
Sell to Cover
2026-01-30
$81,249x2
|
||||||
| NRIX |
Nurix Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Sell to Cover
|
2026-01-30 | $81,249x2 | S | Form 4 |
|
NRIX
S
Nurix Therapeutics, Inc.
Ring Christine
• Officer • Chief Legal Officer
Sell to Cover
2026-01-30
$73,381x2
|
||||||
| NRIX |
Nurix Therapeutics, Inc.
|
Officer • Chief Legal Officer
Sell to Cover
|
2026-01-30 | $73,381x2 | S | Form 4 |
| NRIX |
Nurix Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-01-30 | $60,767x2 | S | Form 4 |
|
NRIX
S
Nurix Therapeutics, Inc.
Ring Christine
• Officer • Chief Legal Officer
10b5-1 Sell
2026-01-20
$69,273
|
||||||
| NRIX |
Nurix Therapeutics, Inc.
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2026-01-20 | $69,273 | S | Form 4 |
|
NRIX
S
Nurix Therapeutics, Inc.
Ring Christine
• Officer • Chief Legal Officer
10b5-1 Sell
2025-12-18
$67,314x2
|
||||||
| NRIX |
Nurix Therapeutics, Inc.
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2025-12-18 | $67,314x2 | S | Form 4 |
|
NRIX
S
Nurix Therapeutics, Inc.
Ring Christine
• Officer • Chief Legal Officer
10b5-1 SellΔOwn -42.5%
2025-11-24
$641,697
|
||||||
| NRIX |
Nurix Therapeutics, Inc.
|
Officer • Chief Legal Officer
10b5-1 SellΔOwn -42.5%
|
2025-11-24 | $641,697 | S | Form 4 |
| NRIX |
Nurix Therapeutics, Inc.
|
CFO
10b5-1 SellΔOwn -14.3%
|
2025-11-03 | $78,931 | S | Form 4 |
|
NRIX
S
Nurix Therapeutics, Inc.
Hansen Gwenn
• Officer • Chief Scientific Officer
Sell to Cover
2025-10-30
$52,300
|
||||||
| NRIX |
Nurix Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Sell to Cover
|
2025-10-30 | $52,300 | S | Form 4 |
|
NRIX
S
Nurix Therapeutics, Inc.
Ring Christine
• Officer • Chief Legal Officer
Sell to Cover
2025-10-30
$46,631
|
||||||
| NRIX |
Nurix Therapeutics, Inc.
|
Officer • Chief Legal Officer
Sell to Cover
|
2025-10-30 | $46,631 | S | Form 4 |
| NRIX |
Nurix Therapeutics, Inc.
|
CFO
Sell to Cover
|
2025-10-30 | $40,054 | S | Form 4 |